As rare disease trials face persistent feasibility challenges, Bayesian designs are gaining momentum by enabling more ...
In the 20th-century statistics wars, Bayesians were underdogs. Now their methods may help speed treatments to market.
一部の結果でアクセス不可の可能性があるため、非表示になっています。
アクセス不可の結果を表示する